Partners News Radboudumc and Radboud University strengthen collaboration with Janssen
17 March 2019

On March 12, Radboudumc and Radboud University have signed a letter of intent for intensified collaboration with Janssen.

This collaboration should enable researchers to link high-quality academic innovative research to the translation capabilities of industry even better. This will result in biomedical, pharmaceutical, and clinical research being available to patients more quickly.

Learn more (in Dutch)

Related news items

Innovation by Predica Diagnostics BV improves cervical cancer screening

26 July 2022

A joint financing round from ION+2 and the Thematic Technology Transfer Medtech Fund (TTT Medtech) allows the further development of molecular diagnostic tests for different cancers by Predica Diagnostics (Nijmegen, NL).

read more

Xenikos enrolls first patient in global pivotal phase 3 study evaluating T-Guard®

30 June 2022 First patient dosed in their Phase 3 study for T-Guard, a candidate for the treatment of severe acute graft-versus-host disease (aGVHD). read more

Simmunext: where immunotherapy and chemistry meet

2 June 2022 The story behind Radboud university medical center’s, Radboud University’s and Oncode’s newest spinoff, Simmunext Biotherapeutics B.V. read more

Investment in ARNE helps neonatologists make better decisions when treating newborn babies

28 April 2022 ARNE B.V. has raised financing from Oost NL and venture builder NLC. ARNE supplies smart software with which neonatologists can make decisions based on data after the birth of a child. read more

BIOTRIP vision for biotech incubator

9 November 2021 BIOTRIP, the biotech incubator, presents its vision. read more

Meet BabyChecker!

24 September 2021 On September 20th, 2021, Delft Imaging launched BabyChecker: an affordable and portable smartphone-based ultrasound solution. read more